FDA Inspection
Bracco Diagnostics, Inc.Bracco Diagnostics, Inc. – FDA Inspection, Jun 13, 2013
Record Details
This FDA Inspection record concerns Bracco Diagnostics, Inc., with an inspection on June 13, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bracco Diagnostics, Inc.
- Inspection Date
- June 13, 2013
- Product Type
- Drugs
View Company Profile
ID · 714d2364-c60a-4f76-b077-a99988f35c2a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 837980
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.68(b)input/output verification
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.180(e)(1)Review of representative number of batches
- 21 CFR 212.40(b)Written specifications - components
- 21 CFR 212.20(e)Written QA procedures established, followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bracco Diagnostics, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 27, 2024 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| June 5, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 30, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 27, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bracco Diagnostics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.